Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride
Clinical trial NCT03890055 · UNKNOWN
Trial details
- NCT number
- NCT03890055
- Sponsor
- Chifeng Municipal Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.